Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suna Onengut-Gumuscu

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Immunological Reviews|December 21, 2002
Mapping genes for autoimmunity in humans: type 1 diabetes as a modelSuna Onengut-Gumuscu, Patrick Concannon
Current Opinion in Immunology|August 4, 2006
Recent advances in the immunogenetics of human type 1 diabetesSuna Onengut-Gumuscu, Patrick Concannon
Journal of Autoimmunity|November 3, 2005
The genetics of type 1 diabetes: lessons learned and future challengesSuna Onengut-Gumuscu, Patrick Concannon
Molecular Genetics and Metabolism|April 3, 2004
A functional variant of IRS1 is associated with type 1 diabetes in families from the US and UKV Anne Morrison, Suna Onengut-Gumuscu, Patrick Concannon
Hormone Research|January 21, 2009
Recent progress in the genetics of diabetesStephen S Rich, Suna Onengut-Gumuscu, Patrick Concannon
Current Diabetes Reports|February 7, 2025
Type 1 Diabetes Genetic Risk Scores: History, Application and Future DirectionsMustafa Tosur, Suna Onengut-Gumuscu, Maria J Redondo
Diabetes|September 28, 2006
A haplotype-based analysis of the PTPN22 locus in type 1 diabetesSuna Onengut-Gumuscu, Jane H Buckner, Patrick Concannon
Journal of the Indian Institute of Science|August 4, 2023
Precision Medicine in Type 1 DiabetesDominika A Michalek, Suna Onengut-Gumuscu, David R Repaske, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2025
LAG3+ CD8+ T cell subset drives HR+/HER2- breast cancer reduction in bispecific antibody armed activated T cell therapyRobert Weldon Barnes, Archana Thakur, Suna Onengut-Gumuscu, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
LAG3+ CD8+ T cell Subset Drives HR+/HER2- Breast Cancer Reduction in Bispecific Antibody Armed Activated T Cell TherapyRobert Weldon Barnes, Archana Thakur, Suna Onengut-Gumuscu, et al.
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Immunological Reviews|December 21, 2002
Mapping genes for autoimmunity in humans: type 1 diabetes as a modelSuna Onengut-Gumuscu, Patrick Concannon
Current Opinion in Immunology|August 4, 2006
Recent advances in the immunogenetics of human type 1 diabetesSuna Onengut-Gumuscu, Patrick Concannon
Journal of Autoimmunity|November 3, 2005
The genetics of type 1 diabetes: lessons learned and future challengesSuna Onengut-Gumuscu, Patrick Concannon
Molecular Genetics and Metabolism|April 3, 2004
A functional variant of IRS1 is associated with type 1 diabetes in families from the US and UKV Anne Morrison, Suna Onengut-Gumuscu, Patrick Concannon
Hormone Research|January 21, 2009
Recent progress in the genetics of diabetesStephen S Rich, Suna Onengut-Gumuscu, Patrick Concannon
Current Diabetes Reports|February 7, 2025
Type 1 Diabetes Genetic Risk Scores: History, Application and Future DirectionsMustafa Tosur, Suna Onengut-Gumuscu, Maria J Redondo
Diabetes|September 28, 2006
A haplotype-based analysis of the PTPN22 locus in type 1 diabetesSuna Onengut-Gumuscu, Jane H Buckner, Patrick Concannon
Journal of the Indian Institute of Science|August 4, 2023
Precision Medicine in Type 1 DiabetesDominika A Michalek, Suna Onengut-Gumuscu, David R Repaske, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2025
LAG3+ CD8+ T cell subset drives HR+/HER2- breast cancer reduction in bispecific antibody armed activated T cell therapyRobert Weldon Barnes, Archana Thakur, Suna Onengut-Gumuscu, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
LAG3+ CD8+ T cell Subset Drives HR+/HER2- Breast Cancer Reduction in Bispecific Antibody Armed Activated T Cell TherapyRobert Weldon Barnes, Archana Thakur, Suna Onengut-Gumuscu, et al.
Pageof 13